Korean J Ophthalmol.  2013 Oct;27(5):392-395. 10.3341/kjo.2013.27.5.392.

Surgical Removal of Retained Subfoveal Perfluorocarbon Liquid through a Therapeutic Macular Hole with Intravitreal PFCL Injection and Gas Tamponade

• Kim JM
• Woo SJ
• Park KH
• Chung H

• KMID: 1707297
• DOI: http://doi.org/10.3341/kjo.2013.27.5.392

Abstract

We report two cases of surgical removal of a retained subfoveal perfluorocarbon liquid (PFCL) bubble through a therapeutic macular hole combined with intravitreal PFCL injection and gas tamponade. Two patients underwent pars plana vitrectomy with PFCL injection for rhegmatogenous retinal detachment. In both cases, a retained subfoveal PFCL bubble was noticed postoperatively by funduscopy and optical coherence tomography. Both patients underwent surgical removal of the subfoveal PFCL through a therapeutic macular hole and gas tamponade. The therapeutic macular holes were completely closed by gas tamponade and the procedure yielded a good visual outcome (best-corrected visual acuity of 20 / 40 in both cases). In one case, additional intravitreal PFCL injection onto the macula reduced the size of the therapeutic macular hole and preserved the retinal structures in the macula. Surgical removal of a retained subfoveal PFCL bubble through a therapeutic macular hole combined with intravitreal PFCL injection and gas tamponade provides an effective treatment option.

Keyword

Gas tamponade; Macular hole; Subfoveal perfluorocarbon liquid

MeSH Terms

Aged
Female
Fluorocarbons/*administration & dosage
Follow-Up Studies
Fovea Centralis
Humans
Intravitreal Injections
Retinal Perforations/diagnosis/physiopathology/*surgery
Suction/*methods
Tomography, Optical Coherence
Visual Acuity
Vitrectomy/*methods
Fluorocarbons

Reference

1. Bourke RD, Simpson RN, Cooling RJ, Sparrow JR. The stability of perfluoro-N-octane during vitreoretinal procedures. Arch Ophthalmol. 1996; 114:537–544.

2. Garcia-Valenzuela E, Ito Y, Abrams GW. Risk factors for retention of subretinal perfluorocarbon liquid in vitreoretinal surgery. Retina. 2004; 24:746–752.

3. Berglin L, Ren J, Algvere PV. Retinal detachment and degeneration in response to subretinal perfluorodecalin in rabbit eyes. Graefes Arch Clin Exp Ophthalmol. 1993; 231:233–237.

4. Lee GA, Finnegan SJ, Bourke RD. Subretinal perfluorodecalin toxicity. Aust N Z J Ophthalmol. 1998; 26:57–60.

5. Lai JC, Postel EA, McCuen BW 2nd. Recovery of visual function after removal of chronic subfoveal perfluorocarbon liquid. Retina. 2003; 23:868–870.

6. Lesnoni G, Rossi T, Gelso A. Subfoveal liquid perfluorocarbon. Retina. 2004; 24:172–176.

7. Le Tien V, Pierre-Kahn V, Azan F, et al. Displacement of retained subfoveal perfluorocarbon liquid after vitreoretinal surgery. Arch Ophthalmol. 2008; 126:98–101.

8. Roth DB, Sears JE, Lewis H. Removal of retained subfoveal perfluoro-n-octane liquid. Am J Ophthalmol. 2004; 138:287–289.

9. Garcia-Arumi J, Castillo P, Lopez M, et al. Removal of retained subretinal perfluorocarbon liquid. Br J Ophthalmol. 2008; 92:1693–1694.